Stock Research for PBYI

PBYI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

PBYI Stock Chart & Research Data

The PBYI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PBYI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


PBYI Due diligence Resources & Stock Charts

The PBYI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PBYI Detailed Price Forecast - CNN Money CNN View PBYI Detailed Summary - Google Finance
Yahoo View PBYI Detailed Summary - Yahoo! Finance Zacks View PBYI Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View PBYI Trends & Analysis - Trade-Ideas Barrons View PBYI Major Holders - Barrons
NASDAQ View PBYI Call Transcripts - NASDAQ Seeking View PBYI Breaking News & Analysis - Seeking Alpha
Spotlight View PBYI Annual Report - CompanySpotlight.com OTC Report View PBYI OTC Short Report - OTCShortReport.com
TradeKing View PBYI Fundamentals - TradeKing Charts View PBYI SEC Filings - Bar Chart
WSJ View Historical Prices for PBYI - The WSJ Morningstar View Performance/Total Return for PBYI - Morningstar
MarketWatch View the Analyst Estimates for PBYI - MarketWatch CNBC View the Earnings History for PBYI - CNBC
StockMarketWatch View the PBYI Earnings - StockMarketWatch MacroAxis View PBYI Buy or Sell Recommendations - MacroAxis
Bullish View the PBYI Bullish Patterns - American Bulls Short Pains View PBYI Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View PBYI Stock Mentions - StockTwits PennyStocks View PBYI Stock Mentions - PennyStockTweets
Twitter View PBYI Stock Mentions - Twitter Invest Hub View PBYI Investment Forum News - Investor Hub
Yahoo View PBYI Stock Mentions - Yahoo! Message Board Seeking Alpha View PBYI Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for PBYI - SECform4.com Insider Cow View Insider Transactions for PBYI - Insider Cow
CNBC View PBYI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PBYI - OTC Markets
Yahoo View Insider Transactions for PBYI - Yahoo! Finance NASDAQ View Institutional Holdings for PBYI - NASDAQ


Stock Charts

FinViz View PBYI Stock Insight & Charts - FinViz.com StockCharts View PBYI Investment Charts - StockCharts.com
BarChart View PBYI Stock Overview & Charts - BarChart Trading View View PBYI User Generated Charts - Trading View




Latest Financial News for PBYI


Puma Biotechnology: Recent Developments and Recommendations
Posted on Friday August 10, 2018

In June, the Committee for Medicinal Products for Human Use recommended a favorable opinion on the approval of Puma Biotechnology’s (PBYI) Nerlynx for its commercialization in the European Union for the prolonged adjuvant therapy of adults with early-stage HER2+ (hormone-receptor-positive) breast cancer whose prior adjuvant trastuzumab-based therapy is less than one year from completion.


How Puma Biotechnology Performed in Q2 2018
Posted on Friday August 10, 2018

Puma Biotechnology (PBYI) released its second-quarter earnings results on August 9. It reported net revenue of $117.3 million in the first half of 2018. Puma Biotechnology’s revenue came primarily from its sales of Nerlynx.


Puma Biotech (PBYI) Q2 Loss Narrows, Nerlynx Drives Sales
Posted on Friday August 10, 2018

Puma Biotech (PBYI) posts narrower-than-estimated loss in Q2. Also, rapid growth of its only marketed drug, Nerlynx, boosts sales.


Today's Research Reports on Trending Tickers: Puma Biotechnology and Corcept Therapeutics
Posted on Friday August 10, 2018

NEW YORK, NY / ACCESSWIRE / August 10, 2018 / U.S. markets finished mostly lower on Thursday, as broader market was dragged lower by weak performance from the industrial and energy sector matched with ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.